HOME > ADVOCACY

In This Section

Issues & Advocacy

SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.

LATEST NEWS

  • March 26, 2020 — SNMMI Encourages Legislators To Ensure Accessibility to PPE
    On Thursday, March 26, the Society of Nuclear Medicine and Molecular Imaging joined the American College of Radiology, the American Society of Radiologic Technologists, the American Registry of Radiologic Technologists, the Nuclear Medicine Technologist Certification Board and the Society of Diagnostic Medical Sonography in calling for an adequate supply of personal protective equipment (PPE).
  • March 16, 2020 — Mo-99 Supply Update
    On Monday, March 16, SNMMI President Vasken Dilsizian, MD, released the following statement addressing how the COVID-19 pandemic may affect the supply of Mo-99.
  • March 5, 2020 — *Latest Update:* SNMMI Identifies NCCI Edit Errors
    SNMMI has confirmed that there are incorrect edits in the National Correct Coding Initiative (NCCI) for several of the new and revised CPT codes that went into effect on January 1, 2020.
  • February 18, 2020 — SNMMI Hosts FDA Workshop
    On Friday, February 21, SNMMI and the FDA will be hosting a workshop entitled "PET Drugs: A Workshop on Inspections Management and Regulatory Issues."
  • January 30, 2020 — SNMMI Co-Hosts Congressional Briefing on Capitol Hill: Diagnostic Imaging and Alzheimer’s
    On Wednesday, January 29, the Society of Nuclear Medicine and Molecular Imaging, the Council on Radionuclides and Radiopharmaceuticals (CORAR), and the Medical Imaging Technology Alliance (MITA) co-hosted a congressional briefing entitled: A New Hope: Advancements in Diagnostic Imaging and Alzheimer’s.
  • January 28, 2020 — SNMMI President Vasken Dilsizian, MD, and Josh Mailman Speak at NRC Commissioners Meeting
    SNMMI President Vasken Dilsizian, MD, and patient advocate Josh Mailman participated in the Nuclear Regulatory Commission’s (NRC) Discussion of Medical Uses of Radioactive Materials at the NRC Headquarters in Rockville, Maryland.
  • November 15, 2019 — Good News for Members on CMS PET NCD
    After reviewing the NCDs for PET for Myocardial Perfusion and PET for Myocardial Viability, CMS clarified that PET quantitative myocardial blood flow is coverable under these NCDs.
  • November 4, 2019 — Good News for Nuclear Medicine in CMS Final 2020 MPFS and HOPPS Rules
    On November 1, CMS issued its final rules for HOPPS and MPFS. Thanks to the joint efforts of SNMMI, partner societies, and members, we have great news about nuclear medicine reimbursement for the coming year. Find out more.
    • Click For More Government Relations News

Quicklinks